scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1080/21548331.1993.11442930 |
P698 | PubMed publication ID | 8505393 |
P2093 | author name string | Craig WA | |
P2860 | cites work | Determinants of efficacy and toxicity of aminoglycosides | Q34510814 |
Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats | Q35536118 | ||
Continuous infusion of beta-lactam antibiotics | Q35656806 | ||
Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia | Q35836523 | ||
Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis | Q35867013 | ||
Once-daily aminoglycoside therapy | Q37730823 | ||
Enhancing effect of serum ultrafiltrate on the activity of cephalosporins against gram-negative bacilli | Q39814757 | ||
Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model | Q43617611 | ||
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections | Q54297609 | ||
Adaptive resistance to aminoglycoside antibiotics from first-exposure down-regulation. | Q54319060 | ||
Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment. | Q54383172 | ||
P921 | main subject | antibiotic | Q12187 |
socioeconomics | Q1643441 | ||
P304 | page(s) | 16-20 | |
P577 | publication date | 1993-06-01 | |
P1433 | published in | Hospital practice (Office ed.) | Q27711433 |
P1476 | title | Outpatient parenteral antibiotic therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the antibiotic | |
P478 | volume | 28 Suppl 1 |
Q33938974 | Ambulatory use of parenteral antibacterials: contemporary perspectives |
Q40526811 | Antibiotic kinetics and dynamics for the clinician. |
Q40432517 | Antibiotic selection factors and description of a hospital-based outpatient antibiotic therapy program in the USA |
Q40459002 | Beta-Lactam Antibiotics: Is Continuous Infusion The Preferred Method of Administration? |
Q28375792 | Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis |
Q35627814 | Delivering antibacterials to the lungs: considerations for optimizing outcomes. |
Q80967238 | Infusion phlebitis: relative incidence associated with cefuroxime administered by intermittent and continuous infusion |
Q33539736 | Interrelationship between pharmacokinetics and pharmacodynamics in choosing the appropriate antibiotic and the dosage regimen for treating acute exacerbations of chronic bronchitis. |
Q30426113 | Intravenous antimicrobial therapy in the community: underused, inadequately resourced, or irrelevant to health care in Britain? |
Q72582713 | Is it time to redefine the management of febrile neutropenia in cancer patients? |
Q45927552 | Pharmacokinetics and pharmacodynamics of newer oral cephalosporins: implications for treatment of community-acquired lower respiratory tract infections. |
Q37557851 | Pharmacological rationale for antibiotic treatment of intra-abdominal infections |
Q40284867 | Retain intermittent dosing of carbapenems |
Search more.